Zhang LN - Search Results

1

A model based on CT radiomic features for predicting RT-PCR becoming negative in coronavirus disease 2019 (COVID-19) patients.

Cai Q, Du SY, Gao S, Huang GL, Zhang Z, Li S, Wang X, Li PL, Lv P, Hou G, Zhang LN. Cai Q, et al. Among authors: zhang z, zhang ln. BMC Med Imaging. 2020 Oct 20;20(1):118. doi: 10.1186/s12880-020-00521-z. BMC Med Imaging. 2020. PMID: 33081700 Free PMC article.

2

Contrast-free MRI quantitative parameters for early prediction of pathological response to neoadjuvant chemotherapy in breast cancer.

Du S, Gao S, Zhao R, Liu H, Wang Y, Qi X, Li S, Cao J, Zhang L. Du S, et al. Eur Radiol. 2022 Aug;32(8):5759-5772. doi: 10.1007/s00330-022-08667-w. Epub 2022 Mar 10. Eur Radiol. 2022. PMID: 35267091

3

Delta-Radiomics Based on Dynamic Contrast-Enhanced MRI Predicts Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.

Guo L, Du S, Gao S, Zhao R, Huang G, Jin F, Teng Y, Zhang L. Guo L, et al. Cancers (Basel). 2022 Jul 20;14(14):3515. doi: 10.3390/cancers14143515. Cancers (Basel). 2022. PMID: 35884576 Free PMC article.

4

Time Course Changes of Synthetic Relaxation Time During Neoadjuvant Chemotherapy in Breast Cancer: The Optimal Parameter for Treatment Response Evaluation.

Zhao R, Du S, Gao S, Shi J, Zhang L. Zhao R, et al. J Magn Reson Imaging. 2023 Oct;58(4):1290-1302. doi: 10.1002/jmri.28597. Epub 2023 Jan 9. J Magn Reson Imaging. 2023. PMID: 36621982

5

Potential Antihuman Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer.

Bian X, Du S, Yue Z, Gao S, Zhao R, Huang G, Guo L, Peng C, Zhang L. Bian X, et al. J Magn Reson Imaging. 2023 Nov;58(5):1603-1614. doi: 10.1002/jmri.28628. Epub 2023 Feb 10. J Magn Reson Imaging. 2023. PMID: 36763035

6

Correlation between synthetic MRI relaxometry and apparent diffusion coefficient in breast cancer subtypes with different neoadjuvant therapy response.

Jiang W, Du S, Gao S, Xie L, Xie Z, Wang M, Peng C, Shi J, Zhang L. Jiang W, et al. Insights Imaging. 2023 Sep 29;14(1):162. doi: 10.1186/s13244-023-01492-9. Insights Imaging. 2023. PMID: 37775610 Free PMC article.

7

Multiparametric MRI Radiomics for the Identification of HER2-Low Breast Cancers.

Du S, Gao S, Wang M, Zhang L. Du S, et al. Radiology. 2024 Jan;310(1):e232092. doi: 10.1148/radiol.232092. Radiology. 2024. PMID: 38165249 No abstract available.

8

SwinHR: Hemodynamic-powered hierarchical vision transformer for breast tumor segmentation.

Zhao Z, Du S, Xu Z, Yin Z, Huang X, Huang X, Wong C, Liang Y, Shen J, Wu J, Qu J, Zhang L, Cui Y, Wang Y, Wee L, Dekker A, Han C, Liu Z, Shi Z, Liang C. Zhao Z, et al. Comput Biol Med. 2024 Feb;169:107939. doi: 10.1016/j.compbiomed.2024.107939. Epub 2024 Jan 3. Comput Biol Med. 2024. PMID: 38194781 Free article.

9

Molecular subtypes of breast cancer identified by dynamically enhanced MRI radiomics: the delayed phase cannot be ignored.

Huang G, Du S, Gao S, Guo L, Zhao R, Bian X, Xie L, Zhang L. Huang G, et al. Insights Imaging. 2024 May 31;15(1):127. doi: 10.1186/s13244-024-01713-9. Insights Imaging. 2024. PMID: 38816553 Free PMC article.

10

Role of monocyte tissue factor on patients with non-small cell lung cancer.

Deng C, Wu S, Zhang L, Yang M, Lin Q, Xie Q, Ding H, Lian N, Gao S, Huang Y, Jin Y. Deng C, et al. Clin Respir J. 2018 Mar;12(3):1125-1133. doi: 10.1111/crj.12640. Epub 2017 May 8. Clin Respir J. 2018. PMID: 28419722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

563 results

Search Page

Filters